Macquarie analyst David Konrad upgraded Morgan Stanley to Outperform with a $33 price target on shares. The analyst said the underperforming FICC business has been a drag on ROE and expects recent cuts in the segment to meaningfully improve margins. Konrad views valuation as compelling at 86% of TBV combined with expectations of improving returns for risk-weighted assets and increasing distribution of capital to shareholders.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Notable gainers among liquid option names this morning include UnitedHealth (UNH) $475.73 +30.10, Super Micro (SMCI) $914.90 +32.15, Humana (HUM) $324.54 +9.90, Morgan Stanley (MS) $89.42 +2.43, and Cencora Inc (COR) $238.39 +4.18.
Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER - Macatawa... To see the rest of the story go to thefly.com. See Story Here